Alvotech shares rise after Barclays double upgrade
Alvotech climbed after a Wall Street analyst upgraded the biotech, citing confidence it will receive regulatory approval for three medications later this year.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.